EcoR1 Capital’s Centessa Pharmaceuticals CNTA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | – | Sell |
-6,000,000
| Closed | -$238M | – | 35 |
|
|
2026
Q1 | $238M | Buy |
6,000,000
+2,885,000
| +93% | +$73.8M | 10.11% | 4 |
|
|
2025
Q4 | $77.9M | Buy |
3,115,000
+2,565,000
| +466% | +$65M | 3.53% | 5 |
|
|
2025
Q3 | $13.3M | Buy |
+550,000
| New | +$9.78M | 0.64% | 22 |
|
|
2024
Q4 | – | Sell |
-3,223,851
| Closed | -$51.5M | – | 63 |
|
|
2024
Q3 | $51.5M | Sell |
3,223,851
-2,490,553
| -44% | -$30.5M | 1.76% | 15 |
|
|
2024
Q2 | $51.6M | Buy |
5,714,404
+95,625
| +2% | +$907K | 1.58% | 17 |
|
|
2024
Q1 | $63.5M | Hold |
5,618,779
| – | – | 1.61% | 20 |
|
|
2023
Q4 | $44.7M | Hold |
5,618,779
| – | – | 1.16% | 17 |
|
|
2023
Q3 | $36.4M | Hold |
5,618,779
| – | – | 1.23% | 16 |
|
|
2023
Q2 | $34.8M | Hold |
5,618,779
| – | – | 0.85% | 19 |
|
|
2023
Q1 | $21.6M | Buy |
5,618,779
+386,500
| +7% | +$1.41M | 0.7% | 24 |
|
|
2022
Q4 | $16.2M | Buy |
5,232,279
+1,995,927
| +62% | +$7.4M | 0.49% | 32 |
|
|
2022
Q3 | $13M | Buy |
3,236,352
+2,944,032
| +1,007% | +$13.5M | 0.38% | 35 |
|
|
2022
Q2 | $1.42M | Sell |
292,320
-162,225
| -36% | -$1.04M | 0.05% | 67 |
|
|
2022
Q1 | $4.08M | Sell |
454,545
-427,631
| -48% | -$3.9M | 0.13% | 55 |
|
|
2021
Q4 | $9.93M | Buy |
882,176
+127,631
| +17% | +$1.72M | 0.32% | 37 |
|
|
2021
Q3 | $12.6M | Hold |
754,545
| – | – | 0.44% | 30 |
|
|
2021
Q2 | $16.8M | Buy |
+754,545
| New | +$17.7M | 0.63% | 30 |
|
EcoR1 Capital's CNTA Position: Q2 2026 in Review
EcoR1 Capital sold out of Centessa Pharmaceuticals (CNTA) in Q2 2026, closing a stake of 6,000,000 shares — an estimated $238M sold.
EcoR1 Capital first reported a position in CNTA in Q2 2021 and held it in 17 quarters. The position peaked at $238M in Q1 2026. 0 funds tracked by Wall St. Rank hold CNTA as of Q2 2026.
- EcoR1 Capital reported no remaining Centessa Pharmaceuticals position as of Q2 2026 after selling out during the quarter.
- EcoR1 Capital sold 6,000,000 Centessa Pharmaceuticals shares in Q2 2026, an estimated $238M.
- EcoR1 Capital first reported a position in Centessa Pharmaceuticals in Q2 2021 and held it in 17 quarters.
- EcoR1 Capital's Centessa Pharmaceuticals position peaked at $238M in Q1 2026.
- 0 funds tracked by Wall St. Rank held Centessa Pharmaceuticals as of Q2 2026.
Based on EcoR1 Capital's 13F filing for Q2 2026, filed 14 Aug 2026.